Skip to main content

Advertisement

Log in

A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: Implications for clinical evaluation and treatment

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

22q11 deletion syndrome (22q11DS) is a chromosomal disorder that results in variable multisystem abnormalities, including conotruncal cardiac malformations, aplasia or hypoplasia of the thymus and/or parathyroid glands, immunodeficiency, dysmorphic facial features, and cleft palate and other nasopharyngeal and dental anomalies. Individuals with 22q11DS also exhibit cognitive and behavioral difficulties, including delayed motor and speech-language development, mental retardation, low academic achievement, impaired spatial reasoning, poor attentional and executive functioning, attention-deficit hyperactivity disorder, autism spectrum disorders, mood disorders, and/or schizophrenia spectrum disorders. Interventions should be designed based on the results of periodic developmental and neuropsychological assessments and psychiatric screening. Future research should focus on understanding deletion-related gene-environment interactions and their effects on developmental and behavioral outcomes, identifying neurodegenerative processes in 22q11DS, and developing preventive models of behavioral and psychopharmacologic treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Botto LD, May K, Fernhoff PM, et al.: A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003, 112: 101–107.

    Article  PubMed  Google Scholar 

  2. Oskarsdottir S, Vujic M, Fasth A: Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 2004, 89: 148–151.

    Article  PubMed  CAS  Google Scholar 

  3. Robin N, Shprintzen RJ: Defining the clinical spectrum of deletion 22q11.2. J Pediatr 2005, 147: 90–96.

    Article  PubMed  Google Scholar 

  4. Antshel K, Kates W, Roizen N, et al.: 22Q11.2 deletion syndrome: genetics, neuroanatomy and cognitive/behavioral features. Child Neuropsychol 2005, 11: 5–19.

    Article  PubMed  Google Scholar 

  5. Driscoll DA, Spinner NB, Budarf ML, et al.: Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 1992, 44: 261–268.

    Article  PubMed  CAS  Google Scholar 

  6. Scambler PJ, Carey AH, Wyse RK, et al.: Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 1991, 10: 201–206.

    Article  PubMed  CAS  Google Scholar 

  7. Scambler PJ, Kelly D, Lindsay E, et al.: Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 1992, 339: 1138–1139.

    Article  PubMed  CAS  Google Scholar 

  8. Online Mendelian Inheritance in Man #188400. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM. Accessed December 15, 2006.

  9. Online Mendelian Inheritance in Man #192430. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM. Accessed December 15, 2006.

  10. Goldmuntz E: DiGeorge syndrome: new insights. Clin Perinatol 2005, 32: 963–978.

    Article  PubMed  Google Scholar 

  11. Eicher PS, McDonald-Mcginn DM, Fox CA, et al.: Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J Pediatr 2000, 137: 158–164.

    Article  PubMed  CAS  Google Scholar 

  12. Shprintzen RJ: The velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 2001, 6: 142–147.

    Article  Google Scholar 

  13. Beauchesne LM, Warnes CA, Connolly HM, et al.: Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol 2005, 45: 595–598.

    Article  PubMed  CAS  Google Scholar 

  14. Murphy KC, Owen MJ: Schizophrenia, CATCH 22 and FISH. Br J Psychiatry 1996, 168: 397–398.

    Article  PubMed  CAS  Google Scholar 

  15. Bassett AS, Hodgkinson K, Chow EW, et al.: 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 1998, 81: 328–337.

    Article  PubMed  CAS  Google Scholar 

  16. Bassett AS, Chow EW: 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999, 46: 882–891.

    Article  PubMed  CAS  Google Scholar 

  17. Usiskin SI, Nicolson R, Krasnewich DM, et al.: Velocardiofacial syndrome in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1999, 38: 1536–1543.

    Article  PubMed  CAS  Google Scholar 

  18. Gerdes M, Solot C, Wang PP, et al.: Cognitive and behavioral profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 1999, 85: 127–133.

    Article  PubMed  CAS  Google Scholar 

  19. Lajiness-O’Neill R, Beaulieu I, Asamoah A, et al.: The neuropsychological phenotype of velocardiofacial syndrome (VCFS): relationship to psychopathology. Arch Clin Neuropsychol 2006, 21: 175–184.

    Article  PubMed  Google Scholar 

  20. Sobin C, Kiley-Brabeck K, Daniels S, et al.: Neuropsychological characteristics of children with the 22Q11 deletion syndrome: a descriptive analysis. Child Neuropsychol 2005, 11: 39–53.

    Article  PubMed  Google Scholar 

  21. Gothelf D, Eliez S, Thompson T, et al.: COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 2005, 8: 1500–1502.

    Article  PubMed  CAS  Google Scholar 

  22. Shprintzen RJ, Higgins AM, Antshel K, et al.: Velo-cardiofacial syndrome. Curr Opin Pediatr 2005, 17: 725–730.

    Article  PubMed  Google Scholar 

  23. Swillen A, Feys H, Adriaens T, et al.: Early motor development in young children with 22q.11 deletion syndrome and conotruncal heart defect. Dev Med Child Neurol 2005, 47: 797–802.

    Article  PubMed  Google Scholar 

  24. Solot CB, Knightly C, Handler SD, et al.: Communication disorders in the 22Q11.2 microdeletion syndrome. J Commun Disord 2000, 33: 187–203.

    Article  PubMed  CAS  Google Scholar 

  25. Swillen A, Devriendt K, Legius E, et al.: Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 27 children and adolescents with VCFS. J Med Genet 1997, 34: 453–458.

    Article  PubMed  CAS  Google Scholar 

  26. Swillen A, Vandeputte L, Cracco J, et al.: Neuropsychological, learning, and psychosocial profile of primary school aged children with velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? Child Neuropsychol 1999, 5: 230–241.

    PubMed  CAS  Google Scholar 

  27. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.

    Google Scholar 

  28. Zinkstok J, Amelsvoort T: Neuropsychological profile and neuroimaging in patients with 22Q11.2 deletion syndrome: a review. Child Neuropsychol 2005, 11: 21–37.

    Article  PubMed  Google Scholar 

  29. Wang P, Woodin M, Kreps-Falk R, Moss E: Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2). Dev Med Child Neurol 2000, 42: 422–427.

    Article  PubMed  CAS  Google Scholar 

  30. Moss E, Batshaw M, Solot C, et al.: Psychoeducational profile of the 22q11.2 microdeletion: a complex pattern. J Pediatr 1999, 134: 193–198.

    Article  PubMed  CAS  Google Scholar 

  31. Bearden CE, Woodin MF, Wang PP: The neurocognitive phenotype of the 22q11.2 deletion syndrome: selective deficit in visual-spatial memory. J Clin Exp Neuropsychol 2001, 23: 447–464.

    Article  PubMed  CAS  Google Scholar 

  32. Woodin M, Wang P, Aleman D, et al.: Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet Med 2001, 3: 34–39.

    PubMed  CAS  Google Scholar 

  33. van Amelsvoort T, Henry J, Morris R, et al.: Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res 2004, 70: 223–232.

    Article  PubMed  Google Scholar 

  34. Fine SE, Weissman A, Gerdes M, et al.: Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 2005, 35: 461–470.

    Article  PubMed  Google Scholar 

  35. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C: Neuropsychiatric disorders in the 22q11 deletion syndrome. Genet Med 2001, 3: 79–84.

    PubMed  CAS  Google Scholar 

  36. Vorstman JA, Morcus ME, Duijff SN, et al.: The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 2006, 45: 1104–1112.

    Article  PubMed  Google Scholar 

  37. Antshel KM, Aneja A, Strunge L, et al.: Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). J Autism Dev Disord 2006 [Epub ahead of print].

  38. Zagursky K, Weller RA, Jessani N, et al.: Prevalence of ADHD in children with velocardiofacial syndrome: a preliminary report. Curr Psychiatry Rep 2006, 8: 102–107.

    Article  PubMed  Google Scholar 

  39. Golding-Kushner KJ, Weller G, Shprintzen RJ: Velo-cardiofacial syndrome: language and psychological profiles. J Craniofac Genet Dev Biol 1985, 5: 259–266.

    PubMed  CAS  Google Scholar 

  40. Gothelf D, Lombroso PJ: Genetics of childhood disorders: XXV. Velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 2001, 40: 489–491.

    Article  PubMed  CAS  Google Scholar 

  41. Feinstein C, Eliez S, Blasey C, Reiss AL: Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 2002, 51: 312–318.

    Article  PubMed  Google Scholar 

  42. Murphy K, Jone L, Owen M: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56: 940–945.

    Article  PubMed  CAS  Google Scholar 

  43. White P, Chant D, Edwards N, et al.: Prevalence of intellectual disability and comorbid mental illness in an Australian community sample. Aust N Z J Psychiatry 2005, 39: 395–400.

    Article  PubMed  Google Scholar 

  44. Weller EB, Rowan A, Elia J, Weller RA: Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders. J Clin Psychiatry 1999, 60(Suppl 15): 5–11.

    PubMed  Google Scholar 

  45. Williams NM, Owen MJ: Genetic abnormalities of chromosome 22 and the development of psychosis. Curr Psychiatry Rep 2004, 6: 176–182.

    Article  PubMed  Google Scholar 

  46. Baker KD, Skuse DH: Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychol 2005, 186: 115–120.

    Article  Google Scholar 

  47. Debbane M, Glaser B, David MK, et al.: Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 2006, 84: 187–193.

    Article  PubMed  Google Scholar 

  48. Cornblatt BA: The New York high risk project to the Hillside recognition and prevention (RAP) program. Am J Med Genet 2002, 114: 956–966.

    Article  PubMed  Google Scholar 

  49. McGorry PD, McKenzie D, Jackson HJ, et al.: Can we improve the diagnostic efficiency and predictive power of prodromal symptoms of schizophrenia? Schizophr Res 2000, 42: 91–100.

    Article  PubMed  CAS  Google Scholar 

  50. Carlson C, Papolos D, Pandita RK, et al.: Molecular analysis of velo-cardio-facial syndrome in patients with psychiatric disorders. Am J Hum Genet 1997, 60: 851–859.

    PubMed  CAS  Google Scholar 

  51. Arnold PD, Siegel-Bartelt J, Cytrynbaum C, et al.: Velo-cardio-facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet 2001, 105: 354–362.

    Article  PubMed  CAS  Google Scholar 

  52. Papolos DF, Faedda GL, Veit S, et al.: Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: Does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996, 153: 1541–1547.

    PubMed  CAS  Google Scholar 

  53. Pulver AE, Nestadt G, Goldberg R, et al.: Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994, 182: 476–478.

    Article  PubMed  CAS  Google Scholar 

  54. Antshel KM, Fremont W, Roizen NJ, et al.: ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 2006, 45: 596–603.

    Article  PubMed  Google Scholar 

  55. Gerdes M, Solot C, Wang P, et al.: Taking advantage of early diagnosis: preschool children with the 22q11.2 deletion. Genet Med 2001, 3: 40–44.

    Article  PubMed  CAS  Google Scholar 

  56. Solot C, Gerdes M, Kirschner R, et al.: Communication issues in 22q11.2 deletion syndrome: children at risk. Genet Med 2001, 3: 67–71.

    PubMed  CAS  Google Scholar 

  57. Ramey C, Ramey SL: Early intervention and early experience. Am Psychol 1998, 53: 109–120.

    Article  PubMed  CAS  Google Scholar 

  58. Stone WL, Yoder PJ: Predicting spoken language level in children with autism spectrum disorders. Autism 2001, 5: 341–361.

    Article  PubMed  CAS  Google Scholar 

  59. National Research Council: Educating Children with Autism. Committee on Educational Interventions for Children with Autism. Washington, DC: Division of Behavioral and Social Sciences and Education; 2001.

    Google Scholar 

  60. Blomquist KB: Health, education, work, and independence of young adults with disabilities. Orthop Nurs 2006, 25: 168–187.

    Article  PubMed  Google Scholar 

  61. Gothelf D, Frisch A, Munitz H, et al.: Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophr Res 1999, 35: 105–112.

    Article  PubMed  CAS  Google Scholar 

  62. Debbane M, Glaser B, David MK, et al.: Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 2006, 84: 187–193.

    Article  PubMed  Google Scholar 

  63. Scuccimarri R, Rodd C: Thyroid abnormalities as a feature of DiGeorge syndrome: a patient report and review of the literature. J Pediatr Endocrinol Metab 1998, 11: 273–276.

    PubMed  CAS  Google Scholar 

  64. Murphy KC: Annotation: velo-cardio-facial syndrome. J Child Psychol Psychiatry 2005, 46: 563–571.

    Article  PubMed  CAS  Google Scholar 

  65. Papolos DF, Faedda GL, Veit S, et al.: Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: Does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996, 153: 1541–1547.

    PubMed  CAS  Google Scholar 

  66. Gothelf D, Presburger G, Zohar AH, et al.: Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet B Neuropsychiatr Genet 2004, 126: 99–105.

    Article  Google Scholar 

  67. Karayiorgou M, Morris MA, Morrow B, et al.: Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A 1995, 92: 7612–7616.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Opal Ousley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ousley, O., Rockers, K., Dell, M.L. et al. A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: Implications for clinical evaluation and treatment. Curr Psychiatry Rep 9, 148–158 (2007). https://doi.org/10.1007/s11920-007-0085-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-007-0085-8

Keywords

Navigation